Pharmacy Freak Editorial Team 
Introduction Anticoagulants are blood-thinning agents that prevent the formation and extension of blood clots (thrombi) in the vascular system. Mechanism of Action of Anticoagulant Drugs involves inhibition of key factors in the coagulation cascade, thereby interfering with fibrin clot formation. Unlike thrombolytics, which dissolve existing clots, anticoagulants prevent new clot formation and are essential in … Read more
Offences and penalties under sale provisions MCQs With Answer This concise, focused review of offences and penalties under sale provisions is designed for B. Pharm students preparing for exams and professional practice. It explains key concepts in pharmacy law—sale provisions, authorised sale, unauthorised sale, misbranding, adulteration, spurious drugs, record-keeping, and prescription requirements—highlighting legal liabilities and … Read more
Restricted license for sale of drugs is a crucial regulatory concept for B.Pharm students, covering legal, clinical and operational aspects of dispensing controlled medicines. This introduction explains licensing types, eligibility, documentation, record-keeping, storage, and compliance with the Drugs and Cosmetics Act and NDPS rules. Emphasis is on distinctions between retail, wholesale and restricted licenses, responsibilities … Read more
Retail sale of drugs – licensing and control is an essential topic for B.Pharm students, covering legal framework, permits, and regulatory oversight that ensure safe dispensing. This module explains drug retail licensing, the Drugs and Cosmetics Act and Rules, roles of State Drug Authorities and drug inspectors, requirements for registered pharmacists, prescription-only categories (Schedule H, … Read more
Introduction: The wholesale sale of drugs involves regulated distribution, licensing, and stringent control measures to ensure safe supply chains and public health. B. Pharm students must understand licensing procedures, State drug control authorities, Good Distribution Practices (GDP), storage and transportation requirements, record keeping, prescription categories such as Schedule H and Schedule X, inspection protocols, and … Read more
Introduction: The DMR (OA) – Drugs (Magic Remedies) rules MCQs With Answer provide B.Pharm students a focused review of the Drugs and Magic Remedies (Objectionable Advertisements) framework, regulatory scope, and ethical advertising practices. This concise guide covers definitions, prohibited claims, advertising media (print, TV, social media), Schedule-listed conditions, industry responsibilities, compliance steps, and pharmacist roles … Read more
Sterile compounding of IV admixtures is one of the most safety-critical tasks in hospital pharmacy. A single lapse in aseptic technique, environmental control, or labeling can seed an infection, cause emboli, or deliver the wrong drug or dose. That is why understanding and applying USP <797> is non-negotiable. The standard turns best practice into measurable, … Read more
Introduction Schedule F in the Drugs and Cosmetics framework outlines detailed regulatory requirements for biologicals and certain pharmaceutical products, emphasizing manufacturing standards, monographs, quality control tests, labelling and documentation. For B. Pharm students, understanding Schedule F’s details and significance is essential for safe production, release testing, regulatory compliance and pharmacovigilance. Key concepts include sterility, potency, … Read more
Part XII B – Details and Significance is a focused study module for B.Pharm students covering regulatory compliance, quality assurance, good manufacturing practices (GMP), documentation, inspection readiness, and patient safety. This section explains the objectives, scope, and operational elements such as SOPs, batch records, validation, stability studies, change control, and corrective and preventive actions (CAPA). … Read more
Schedule Y – details and significance MCQs With Answer is an essential introduction for B. Pharm students studying Indian drug regulation and clinical trial governance. This concise guide explains Schedule Y provisions on clinical trial approval, phase-wise trial design, investigator and sponsor responsibilities, informed consent, Institutional Ethics Committee (IEC) review, bioavailability/bioequivalence (BA/BE) studies, and pharmacovigilance. … Read more
